Our work carries on the previously identified novel mutation in MEN1 gene12 such as S606F which results in the disruption of menin-regulator interacting sites that result in the presentation of multiple endocrine tumors such as a parathyroid tumor, pancreatic endocrine tumor, and pituitary adenoma. Here, MEN1 is linked to pancreatic neuroendocrine tumor.